Cargando…

Receptor oligomerization and beyond: a case study in bone morphogenetic proteins

BACKGROUND: Transforming growth factor (TGF)β superfamily members transduce signals by oligomerizing two classes of serine/threonine kinase receptors, termed type I and type II. In contrast to the large number of ligands only seven type I and five type II receptors have been identified in mammals, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Heinecke, Kai, Seher, Axel, Schmitz, Werner, Mueller, Thomas D, Sebald, Walter, Nickel, Joachim
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2749821/
https://www.ncbi.nlm.nih.gov/pubmed/19735544
http://dx.doi.org/10.1186/1741-7007-7-59
_version_ 1782172187291025408
author Heinecke, Kai
Seher, Axel
Schmitz, Werner
Mueller, Thomas D
Sebald, Walter
Nickel, Joachim
author_facet Heinecke, Kai
Seher, Axel
Schmitz, Werner
Mueller, Thomas D
Sebald, Walter
Nickel, Joachim
author_sort Heinecke, Kai
collection PubMed
description BACKGROUND: Transforming growth factor (TGF)β superfamily members transduce signals by oligomerizing two classes of serine/threonine kinase receptors, termed type I and type II. In contrast to the large number of ligands only seven type I and five type II receptors have been identified in mammals, implicating a prominent promiscuity in ligand-receptor interaction. Since a given ligand can usually interact with more than one receptor of either subtype, differences in binding affinities and specificities are likely important for the generation of distinct ligand-receptor complexes with different signaling properties. RESULTS: In vitro interaction analyses showed two different prototypes of binding kinetics, 'slow on/slow off' and 'fast on/fast off'. Surprisingly, the binding specificity of ligands to the receptors of one subtype is only moderate. As suggested from the dimeric nature of the ligands, binding to immobilized receptors shows avidity due to cooperative binding caused by bivalent ligand-receptor interactions. To compare these in vitro observations to the situation in vivo, binding studies on whole cells employing homodimeric as well as heterodimeric bone morphogenetic protein 2 (BMP2) mutants were performed. Interestingly, low and high affinity binding sites were identified, as defined by the presence of either one or two BMP receptor (BMPR)-IA receptor chains, respectively. Both sites contribute to different cellular responses in that the high affinity sites allow a rapid transient response at low ligand concentrations whereas the low affinity sites facilitate sustained signaling but higher ligand concentrations are required. CONCLUSION: Binding of a ligand to a single high affinity receptor chain functioning as anchoring molecule and providing sufficient complex stability allows the subsequent formation of signaling competent complexes. Another receptor of the same subtype, and up to two receptors of the other subtype, can then be recruited. Thus, the resulting receptor arrangement can principally consist of four different receptors, which is consistent with our interaction analysis showing low ligand-receptor specificity within one subtype class. For BMP2, further complexity is added by the fact that heterooligomeric signaling complexes containing only one type I receptor chain can also be found. This indicates that despite prominent ligand receptor promiscuity a manifold of diverse signals might be generated in this receptor limited system.
format Text
id pubmed-2749821
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27498212009-09-24 Receptor oligomerization and beyond: a case study in bone morphogenetic proteins Heinecke, Kai Seher, Axel Schmitz, Werner Mueller, Thomas D Sebald, Walter Nickel, Joachim BMC Biol Research Article BACKGROUND: Transforming growth factor (TGF)β superfamily members transduce signals by oligomerizing two classes of serine/threonine kinase receptors, termed type I and type II. In contrast to the large number of ligands only seven type I and five type II receptors have been identified in mammals, implicating a prominent promiscuity in ligand-receptor interaction. Since a given ligand can usually interact with more than one receptor of either subtype, differences in binding affinities and specificities are likely important for the generation of distinct ligand-receptor complexes with different signaling properties. RESULTS: In vitro interaction analyses showed two different prototypes of binding kinetics, 'slow on/slow off' and 'fast on/fast off'. Surprisingly, the binding specificity of ligands to the receptors of one subtype is only moderate. As suggested from the dimeric nature of the ligands, binding to immobilized receptors shows avidity due to cooperative binding caused by bivalent ligand-receptor interactions. To compare these in vitro observations to the situation in vivo, binding studies on whole cells employing homodimeric as well as heterodimeric bone morphogenetic protein 2 (BMP2) mutants were performed. Interestingly, low and high affinity binding sites were identified, as defined by the presence of either one or two BMP receptor (BMPR)-IA receptor chains, respectively. Both sites contribute to different cellular responses in that the high affinity sites allow a rapid transient response at low ligand concentrations whereas the low affinity sites facilitate sustained signaling but higher ligand concentrations are required. CONCLUSION: Binding of a ligand to a single high affinity receptor chain functioning as anchoring molecule and providing sufficient complex stability allows the subsequent formation of signaling competent complexes. Another receptor of the same subtype, and up to two receptors of the other subtype, can then be recruited. Thus, the resulting receptor arrangement can principally consist of four different receptors, which is consistent with our interaction analysis showing low ligand-receptor specificity within one subtype class. For BMP2, further complexity is added by the fact that heterooligomeric signaling complexes containing only one type I receptor chain can also be found. This indicates that despite prominent ligand receptor promiscuity a manifold of diverse signals might be generated in this receptor limited system. BioMed Central 2009-09-07 /pmc/articles/PMC2749821/ /pubmed/19735544 http://dx.doi.org/10.1186/1741-7007-7-59 Text en Copyright © 2009 Heinecke et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Heinecke, Kai
Seher, Axel
Schmitz, Werner
Mueller, Thomas D
Sebald, Walter
Nickel, Joachim
Receptor oligomerization and beyond: a case study in bone morphogenetic proteins
title Receptor oligomerization and beyond: a case study in bone morphogenetic proteins
title_full Receptor oligomerization and beyond: a case study in bone morphogenetic proteins
title_fullStr Receptor oligomerization and beyond: a case study in bone morphogenetic proteins
title_full_unstemmed Receptor oligomerization and beyond: a case study in bone morphogenetic proteins
title_short Receptor oligomerization and beyond: a case study in bone morphogenetic proteins
title_sort receptor oligomerization and beyond: a case study in bone morphogenetic proteins
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2749821/
https://www.ncbi.nlm.nih.gov/pubmed/19735544
http://dx.doi.org/10.1186/1741-7007-7-59
work_keys_str_mv AT heineckekai receptoroligomerizationandbeyondacasestudyinbonemorphogeneticproteins
AT seheraxel receptoroligomerizationandbeyondacasestudyinbonemorphogeneticproteins
AT schmitzwerner receptoroligomerizationandbeyondacasestudyinbonemorphogeneticproteins
AT muellerthomasd receptoroligomerizationandbeyondacasestudyinbonemorphogeneticproteins
AT sebaldwalter receptoroligomerizationandbeyondacasestudyinbonemorphogeneticproteins
AT nickeljoachim receptoroligomerizationandbeyondacasestudyinbonemorphogeneticproteins